Dec 19 (Reuters) - The U.S. Food and Drug Administration said on Friday it has authorized the marketing of six Altria-owned on! PLUS nicotine pouch products, through a pilot program aimed to fast-track reviews of such products.
The authorization was the first under the pilot program that the FDA launched in September, and applies to six on! PLUS nicotine pouches, which are manufactured by Helix Innovations LLC, an Altria joint venture for the global on! PLUS nicotine pouch portfolio.
The company had applied for premarket authorization for the products in June 2024.
The decision allows the mint, tobacco and wintergreen-flavored pouches, offered in 6 mg and 9 mg nicotine strengths, to be legally sold to adults in the United States.
The FDA said its decision was based on evidence that the products contain lower levels of harmful chemicals, posing a lower risk of cancer and other serious health conditions compared to other smokeless tobacco products. The authorization applies only to the specified products and not to other Helix offerings.
Nicotine pouches, which users insert under the lip, are the fastest-growing category of tobacco products in the U.S., and are generally considered among the lowest-risk smoking alternatives given they do not involve inhalation and do not contain tobacco.
Earlier this year, 20 Zyn products, owned by Philip Morris became the first in the nicotine pouch category to receive market authorization from the FDA in the U.S.
Zyn products were approved in January, more than five years after the company first submitted its application.
Tobacco companies have invested heavily in developing and marketing alternatives to cigarettes as demand for these products grows.
"on! PLUS will resume taking new orders for retail accounts in Florida, North Carolina and Texas and on e-commerce soon," Altria said to Reuters.
Nicotine in adolescence can harm the parts of the brain that control attention, learning, mood and impulse control, according to the U.S. Centers for Disease Control and Prevention.
(Reporting by Sanskriti Shekhar and Juveria Tabassum in Bengaluru; Editing by Alan Barona)
latest_posts
- 1
From invasive species tracking to water security – what’s lost with federal funding cuts at US Climate Adaptation Science Centers - 2Qantas and Virgin Australia Ban Power Bank Usage on Flights Following Safety Incidents
- 3Culinary Joys: Investigating Connoisseur Cooking at Home
- 4Rocket shines under the northern lights | Space photo of the day for March 25, 2026
- 5Selena Quintanilla documentary 'Selena y Los Dinos: A Family's Legacy' is coming to Netflix
- Danish warship sunk by famed British admiral discovered after 225 years
- From Certificate to Dollars: College Majors with Extraordinary Monetary Prizes
- UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- Agios Pharma shares jump as US FDA expands approval for its blood disorder drug
- What to expect from the planets in 2026 — key dates and sky events
- Russian strikes on Ukraine kill 5 people and wound 30 more
- Activist vessel collides with krill trawler in Antarctic confrontation
- Creative Style: 10 Architects Reclassifying the Business
- A Manual for the Right SUV for Seniors
